Lyra Therapeutics Inc.

NASDAQ: LYRA · Real-Time Price · USD
25.22
2.40 (10.52%)
At close: Jun 05, 2025, 3:59 PM
25.43
0.83%
Pre-market: Jun 06, 2025, 08:33 AM EDT

Lyra Therapeutics Statistics

Share Statistics

Lyra Therapeutics has 1.33M shares outstanding. The number of shares has increased by -0.59% in one year.

1.33M
-0.59%
0.65%
41.07%
n/a
113
0.02%

Short Selling Information

The latest short interest is 7.33M, so 11.06% of the outstanding shares have been sold short.

7.33M
11.06%
13.84%
1

Valuation Ratios

The PE ratio is -0.14 and the forward PE ratio is -0.81. Lyra Therapeutics's PEG ratio is -0.01.

-0.14
-0.81
8.76
0.3
1.16
-0.19
-0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Lyra Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 3.41, with a Debt / Equity ratio of 2.97.

3.41
3.41
2.97
-0.57
-0.48
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$51,133.33
$-3,114,500
30
0.02
n/a

Taxes

39K
-0.04%

Stock Price Statistics

The stock price has increased by 57.62% in the last 52 weeks. The beta is 0.01, so Lyra Therapeutics's price volatility has been higher than the market average.

0.01
57.62%
6.66
10.02
74.78
602,758

Income Statement

In the last 12 months, Lyra Therapeutics had revenue of 1.53M and earned -93.44M in profits. Earnings per share was -71.5.

1.53M
1.06M
-96.35M
-93.44M
-60.26M
-60.73M
-71.5
Full Income Statement

Balance Sheet

The company has 40.58M in cash and 34.38M in debt, giving a net cash position of 6.2M.

40.58M
34.38M
6.2M
-404.79M
56.32M
22.43M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -70.01M and capital expenditures -2.34M, giving a free cash flow of -72.35M.

-70.01M
-2.34M
-72.35M
-55.56
Full Cash Flow Statement

Margins

Gross margin is 69.3%, with operating and profit margins of -6280.83% and -6090.94%.

69.3%
-6280.83%
-6088.4%
-6090.94%
-3928.42%
-6280.83%
-4716.36%

Dividends & Yields

LYRA does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for LYRA is $100, which is 296.5% higher than the current price. The consensus rating is "Hold".

$100
296.5%
Hold
2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on May 28, 2025. It was a backward split with a ratio of 1:50.

May 28, 2025
backward
1:50

Scores

-12.1
3